{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T23:02:35Z","timestamp":1775775755207,"version":"3.50.1"},"reference-count":42,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This study investigated the implication of monitoring hypertensive disorders in pregnancy (HDP) to prevent preeclampsia (PE) in pregnant women of advanced maternal age. Between January 2016 and April 2021, 262 consecutive pregnant women aged \u226540 years were recruited. Extensive monitoring of hypertensive disorders in pregnancy, including blood hypercoagulability screening and subsequent interventions, was performed in 129 pregnant women in our university hospital. The remaining 133 patients from other centres, who did not receive antenatal maternal pregnancy screening and preventive intervention during the same period, constituted the non-intervention group enabling comparison to mimic a trial. The incidences of hypertensive disorders, mild and severe PE, eclampsia, and chronic hypertension complicated by PE in the intervention group were significantly lower than in the non-intervention group (10.08 versus 20.30%, 8.52 versus 18.80%, 7.75 versus 21.05%, 0 versus 3.01%, and 3.86 versus 15.04%, respectively; <jats:italic>P<\/jats:italic> &lt; 0.05). Premature birth, low birth weight, and foetal loss were significantly rarer in the intervention group than in the non-intervention group (6.98 versus 24.81%, 7.75 versus 21.80%, and 0.78 versus 14.29% respectively; <jats:italic>P<\/jats:italic> &lt; 0.001). The comparison of MP with routine blood coagulation biochemical examination found that the MP detection system of Beijing Yes Medical Devices Co., Ltd., had similar sensitivity as thromboelastogram. Still, it was significantly better than the routine biochemical indicators (<jats:italic>P<\/jats:italic> &lt; 0.01). Based on MP parameters, early anticoagulant treatment with low-molecular-weight heparin or low-dose aspirin in pregnant women with hypercoagulability can effectively prevent the occurrence of PE and significantly improve the prognosis of both mothers and infants.<\/jats:p>","DOI":"10.1515\/med-2022-0560","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T14:39:31Z","timestamp":1669127971000},"page":"1840-1848","source":"Crossref","is-referenced-by-count":7,"title":["Monitoring hypertensive disorders in pregnancy to prevent preeclampsia in pregnant women of advanced maternal age: Trial mimicking with retrospective data"],"prefix":"10.1515","volume":"17","author":[{"given":"Yali","family":"Deng","sequence":"first","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifei","family":"She","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Maternal and Child Health Hospital of Hunan Province , Changsha 410000 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoye","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Sanya Central Hospital (Hainan Third People\u2019s Hospital) , Sanya 572000 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weisi","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songyuan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Maternal and Child Health Hospital in Yuanjiang City , Yuanjiang 413111 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Affiliated Hospital of Xiangnan University , Chenzhou 423000 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiling","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, The Second Xiangya Hospital of Central South University , No. 139 People\u2019s Middle Road , Changsha 410011 , P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"2022120618375238291_j_med-2022-0560_ref_001","doi-asserted-by":"crossref","unstructured":"Jiang L, Tang K, Magee LA, von Dadelszen P, Ekeroma A, Li X, et al. A global review of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol. 2022;18(12):760\u201375. 10.1038\/s41574-022-00734-y.","DOI":"10.1038\/s41574-022-00734-y"},{"key":"2022120618375238291_j_med-2022-0560_ref_002","doi-asserted-by":"crossref","unstructured":"Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999\u20131011.","DOI":"10.1016\/S0140-6736(15)00070-7"},{"key":"2022120618375238291_j_med-2022-0560_ref_003","doi-asserted-by":"crossref","unstructured":"Baptista FS, Bortolotto MRFL, Bianchini FRM, Krebs VLJ, Zugaib M, Francisco RPV. Can thrombophilia worsen maternal and perinatal outcomes of severe pre-eclampsia? Preg Hypertens. 2018;11:81\u20136.","DOI":"10.1016\/j.preghy.2017.12.012"},{"key":"2022120618375238291_j_med-2022-0560_ref_004","doi-asserted-by":"crossref","unstructured":"Bakrania BA, Spradley FT, Drummond HA, LaMarca B, Ryan MJ, Granger JP. Preeclampsia: linking placental ischemia with maternal\u2002endothelialand vascular dysfunction. Compr Physiol. 2020;11:1315\u201349.","DOI":"10.1002\/cphy.c200008"},{"key":"2022120618375238291_j_med-2022-0560_ref_005","doi-asserted-by":"crossref","unstructured":"Youssef L, Miranda J, Blasco M, Paules C, Crovetto F, Palomo M, et al. Complement and\u2002coagulation cascades activation is the main pathophysiological pathway in early-onset severe\u2002preeclampsia revealed by maternal proteomics. Sci Rep. 2021;11:3048.","DOI":"10.1038\/s41598-021-82733-z"},{"key":"2022120618375238291_j_med-2022-0560_ref_006","doi-asserted-by":"crossref","unstructured":"Lidan H, Jianbo W, Liqin G, Jifen H, Lin L, Xiuyan W. The Diagnostic Efficacy of\u2002Thrombelastography(TEG) in Patients with Preeclampsia and its Association with Blood Coagulation. Open Life Sci. 2019;14:335\u201341.","DOI":"10.1515\/biol-2019-0037"},{"key":"2022120618375238291_j_med-2022-0560_ref_007","doi-asserted-by":"crossref","unstructured":"Okoye HC, Eweputanna LI, Okpani AO, Ejele OA. Associations between pre-eclampsia and protein C and proteinS levels among pregnant Nigerian women. Int J Gynecol Obstet. 2017;137:26\u201330.","DOI":"10.1002\/ijgo.12085"},{"key":"2022120618375238291_j_med-2022-0560_ref_008","doi-asserted-by":"crossref","unstructured":"Oladosu-Olayiwola O, Olawumi H, Babatunde A, Ijaiya M, Durotoye I, Biliaminu S, et al. Fibrinolyticproteinsof normal pregnancy and\u2002pre-eclamptic patients in North West Nigeria. Afr Health Sci. 2018;18:576\u201383.","DOI":"10.4314\/ahs.v18i3.15"},{"key":"2022120618375238291_j_med-2022-0560_ref_009","doi-asserted-by":"crossref","unstructured":"Feldstein O, Kovo M, Tal O, Braunstein M, Grinstein E, Schreiber L, et al. The association between abnormal coagulation testing in preeclampsia, adverse pregnancy outcomes, and placental histopathology. Hypertens Pregnancy. 2019;38:176\u201383.","DOI":"10.1080\/10641955.2019.1638396"},{"key":"2022120618375238291_j_med-2022-0560_ref_010","unstructured":"Sun JH, Wang LQ, Qi HB. Effect of low molecular weight heparin calcium on clinical efficacy, maternal serological parameters and maternal and infant outcomes in patients with early onset severe preeclampsia. Med J West China. 2018;30(11):1583\u20138."},{"key":"2022120618375238291_j_med-2022-0560_ref_011","doi-asserted-by":"crossref","unstructured":"Miller EC. Preeclampsia and cerebrovascular disease: the maternal brain at risk. Hypertension. 2019;74:5\u201313.","DOI":"10.1161\/HYPERTENSIONAHA.118.11513"},{"key":"2022120618375238291_j_med-2022-0560_ref_012","doi-asserted-by":"crossref","unstructured":"Hobson SR, Gurusinghe S, Lim R, Alers NO, Miller SL, Kingdom JC, et al. Melatonin improves endothelial function in vitro and prolongs pregnancy in women with early onset preeclampsia. Pineal Res. 2018;65:508\u201311.","DOI":"10.1111\/jpi.12508"},{"key":"2022120618375238291_j_med-2022-0560_ref_013","doi-asserted-by":"crossref","unstructured":"Peng M, Yang M, Ding Y, Yu L, Deng Y, Lai W, et al. Mechanism of endogenous digitalis-like factor-induced vascular endothelial cell damage in patients with severe preeclampsia. Int J Mol Med. 2018;41:985\u201394.","DOI":"10.3892\/ijmm.2017.3316"},{"key":"2022120618375238291_j_med-2022-0560_ref_014","doi-asserted-by":"crossref","unstructured":"Chiofalo B, Lagan\u00e0 AS, Vaiarelli A, La Rosa VL, Rossetti D, Palmara V, et al. Do miRNAs play a role in fetal growth restriction? A fresh look to a busy corner. Biomed Res Int. 2017;2017:6073167.","DOI":"10.1155\/2017\/6073167"},{"key":"2022120618375238291_j_med-2022-0560_ref_015","doi-asserted-by":"crossref","unstructured":"Lagan\u00e0 AS, Vitale SG, Sapia F, Valenti G, Corrado F, Padula F, et al. miRNA expression for early diagnosis of preeclampsia onset: hope or hype? J Matern Fetal Neonatal Med. 2018;31(6):817\u201321.","DOI":"10.1080\/14767058.2017.1296426"},{"key":"2022120618375238291_j_med-2022-0560_ref_016","doi-asserted-by":"crossref","unstructured":"Lagan\u00e0 AS, Favilli A, Triolo O, Granese R, Gerli S. Early serum markers of pre-eclampsia: are we stepping forward? J Matern Fetal Neonatal Med. 2016;29(18):3019\u201323.","DOI":"10.3109\/14767058.2015.1113522"},{"key":"2022120618375238291_j_med-2022-0560_ref_017","doi-asserted-by":"crossref","unstructured":"Lagan\u00e0 AS, Giordano D, Loddo S, Zoccali G, Vitale SG, Santamaria A, et al. Decreased endothelial progenitor Cells (EPCs) and increased natural killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis. Arch Gynecol Obstet. 2017;295(4):867\u201372.","DOI":"10.1007\/s00404-017-4296-x"},{"key":"2022120618375238291_j_med-2022-0560_ref_018","unstructured":"Cong KJ, Wang TT, Liu GR. Hemodynamics and microcirculation of pregnancy-induced hypertension syndrome. Chin J Pract Gynecol Obstet. 1997;13:29\u201331."},{"key":"2022120618375238291_j_med-2022-0560_ref_019","unstructured":"Wang HQ, Wang CY, Wu SW. Predictive effect of MP monitoring system on pregnancy-induced hypertension syndrome. J Datong Med Coll. 2004;4(11):14."},{"key":"2022120618375238291_j_med-2022-0560_ref_020","unstructured":"Bao LY, Liang FL, Huang YJ. Predictive effect of pregnancy hypertension monitoring system on pregnancy-induced hypertension syndrome. Guangxi Appl Preven Med. 2001;3:165\u20136."},{"key":"2022120618375238291_j_med-2022-0560_ref_021","unstructured":"Zhao Y, Zou L, Lin T. The value of detecting middle- and late-stage uterine artery blood flow resistance during pregnancy for predicting preeclampsia. Chin J Obstet Gynecol. 2007;42:625\u20137."},{"key":"2022120618375238291_j_med-2022-0560_ref_022","doi-asserted-by":"crossref","unstructured":"Mandal\u00e0 M. Influence of estrogens on\u2002uterinevascular adaptation in normal and preeclamptic pregnancies. Int J Mol Sci. 2020;21:2592.","DOI":"10.3390\/ijms21072592"},{"key":"2022120618375238291_j_med-2022-0560_ref_023","doi-asserted-by":"crossref","unstructured":"Jena MK, Sharma NR, Petitt M, Maulik D, Nayak NR. Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 2020;10:953.","DOI":"10.3390\/biom10060953"},{"key":"2022120618375238291_j_med-2022-0560_ref_024","doi-asserted-by":"crossref","unstructured":"Yang X, Yang Y, Yuan Y, Liu L, Meng T. The roles of uterine natural killer (NK) Cells and KIR\/HLA-C combination in the development of preeclampsia: a systematic review. BioMed Res Int. 2020;2020:4808072.","DOI":"10.1155\/2020\/4808072"},{"key":"2022120618375238291_j_med-2022-0560_ref_025","doi-asserted-by":"crossref","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613\u201322.","DOI":"10.1056\/NEJMoa1704559"},{"key":"2022120618375238291_j_med-2022-0560_ref_026","doi-asserted-by":"crossref","unstructured":"Van Doorn R, Mukhtarova N, Flyke IP, Lasarev M, Kim K, Hennekens CH, et al. Dose of\u2002aspirin\u2002to prevent\u2002preterm\u2002preeclampsia\u2002in women with moderate or\u2002high-risk\u2002factors: A systematic review and meta-analysis. PLoS One. 2021;16:e0247782.","DOI":"10.1371\/journal.pone.0247782"},{"key":"2022120618375238291_j_med-2022-0560_ref_027","doi-asserted-by":"crossref","unstructured":"Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, et al. Low-dose\u2002aspirin\u2002for the prevention of\u2002preterm\u2002delivery in nulliparous women with a singleton\u2002pregnancy: a randomised multi-country\u2002placebo-controlled trial. Lancet. 2020;395:285\u201393.","DOI":"10.1016\/S0140-6736(19)32973-3"},{"key":"2022120618375238291_j_med-2022-0560_ref_028","doi-asserted-by":"crossref","unstructured":"Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2017;369:1791\u20138.","DOI":"10.1016\/S0140-6736(07)60712-0"},{"key":"2022120618375238291_j_med-2022-0560_ref_029","doi-asserted-by":"crossref","unstructured":"Huang J, Chen X, Xing H, Chen L, Xie Z, He S, et al. Aspirin\u2002and heparin for the prevention of\u2002pre-eclampsia: protocol for a systematic review and network meta-analysis. BMJ Open. 2019;9:e026920.","DOI":"10.1136\/bmjopen-2018-026920"},{"key":"2022120618375238291_j_med-2022-0560_ref_030","doi-asserted-by":"crossref","unstructured":"Mone F, Mulcahy C, McParland P, Breathnach F, Downey P, McCormack D, et al. Trial of feasibility and acceptability of routine low-dose\u2002aspirin\u2002versus\u2002Early\u2002Screening\u2002Test indicated\u2002aspirin\u2002for\u2002pre-eclampsia\u2002prevention (TEST\u2002study): a multicentre randomised controlled trial. BMJ Open. 2018;8:e022056.","DOI":"10.1136\/bmjopen-2018-022056"},{"key":"2022120618375238291_j_med-2022-0560_ref_031","doi-asserted-by":"crossref","unstructured":"Katz L, de Amorim MM, Figueiroa JN, Pinto e Silva, JL.  Postpartum dexamethasone for women with hemolysis\uff0celevated liver enzymes, and low platelets (HELLP) syndrome: A double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol. 2008;198:283\u20138.","DOI":"10.1016\/j.ajog.2007.10.797"},{"key":"2022120618375238291_j_med-2022-0560_ref_032","doi-asserted-by":"crossref","unstructured":"Baker LR, Brain MC. Heparin\u2002treatment of haemolytic anaemia and thrombocytopenia in pre-eclampsia. Proc R Soc Med. 1967;60:477\u20139.","DOI":"10.1177\/003591576706000513"},{"key":"2022120618375238291_j_med-2022-0560_ref_033","doi-asserted-by":"crossref","unstructured":"Bolnick AD, Bolnick JM, Kohan-Ghadr HR, Kilburn BA, Pasalodos OJ, Singhal PK, et al. Enhancement of\u2002trophoblast differentiation and survival by\u2002LMWH requires\u2002heparin-binding EGF-like growth factor. Hum Reprod. 2017;32:1218\u201329.","DOI":"10.1093\/humrep\/dex069"},{"key":"2022120618375238291_j_med-2022-0560_ref_034","doi-asserted-by":"crossref","unstructured":"Wat JM, Hawrylyshyn K, Baczyk D, Greig IR, Kingdom JC. Effects of glycol-split\u2002LMWH\u2002on placental, endothelial, and anti-inflammatory pathways relevant to\u2002preeclampsia. Biol Reprod. 2018;99:1082\u201390.","DOI":"10.1093\/biolre\/ioy127"},{"key":"2022120618375238291_j_med-2022-0560_ref_035","doi-asserted-by":"crossref","unstructured":"Pagnini I, Simonini G, Cavalli L, la Marca G, Iuliano A, Brandi ML, et al. Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and\/or\u2002LMWH. Pediatr Rheumatol Online J. 2014;12:47.","DOI":"10.1186\/1546-0096-12-47"},{"key":"2022120618375238291_j_med-2022-0560_ref_036","doi-asserted-by":"crossref","unstructured":"Singh N, Varshney P, Tripathi R, Mala YM, Tyagi S. Safety and efficacy of low molecular weight heparin therapy during pregnancy: three year experience at a tertiary care center. J Obstet Gynaecol India. 2013;63:373\u20137.","DOI":"10.1007\/s13224-013-0412-4"},{"key":"2022120618375238291_j_med-2022-0560_ref_037","doi-asserted-by":"crossref","unstructured":"Paolino M, Koglgruber R, Cronin SJF, Uribesalgo I, Rauscher E, Harreiter J, et al. RANK links thymic regulatory T cells to fetal loss and gestational diabetes in pregnancy. Nature. 2021;589:442\u20137.","DOI":"10.1038\/s41586-020-03071-0"},{"key":"2022120618375238291_j_med-2022-0560_ref_038","doi-asserted-by":"crossref","unstructured":"Nancy P, Erlebacher A. T cell behavior at the maternal-fetal interface. Int J Develop Biol. 2014;58:89\u201398.","DOI":"10.1387\/ijdb.140054ae"},{"key":"2022120618375238291_j_med-2022-0560_ref_039","doi-asserted-by":"crossref","unstructured":"Eghbal-Fard S, Yousefi M, Heydarlou H, Ahmadi M, Taghavi S, Movasaghpour A, et al. The imbalance of Th17\/Treg axis involved in the pathogenesis of preeclampsia. J Cell Physiol. 2019;234:5106\u201316.","DOI":"10.1002\/jcp.27315"},{"key":"2022120618375238291_j_med-2022-0560_ref_040","doi-asserted-by":"crossref","unstructured":"Figueiredo A, Schumacher A. The T helper type 17\/regulatory T cell paradigm in pregnancy. Immunology. 2016;148:13\u201321.","DOI":"10.1111\/imm.12595"},{"key":"2022120618375238291_j_med-2022-0560_ref_041","doi-asserted-by":"crossref","unstructured":"Rasmark Roepke E, Bruno V, Nedstrand E, Boij R, Strid CP, Piccione E, et al. Low-molecular-weight-heparin\u2002increases Th1- and Th17-associated chemokine levels during pregnancy in women with unexplained recurrent pregnancy loss: a randomised controlled trial. Sci Rep. 2019;9:12314.","DOI":"10.1038\/s41598-019-48799-6"},{"key":"2022120618375238291_j_med-2022-0560_ref_042","doi-asserted-by":"crossref","unstructured":"Mondal S, Jana M, Dasarathi S, Roy A, Pahan K. Aspirin\u2002ameliorates experimental autoimmune encephalomyelitis through interleukin-11\u2013mediated protection of regulatory T cells. Sci Signal. 2018;11:eaar8278.","DOI":"10.1126\/scisignal.aar8278"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2022-0560\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2022-0560\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:08:28Z","timestamp":1670368108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/med-2022-0560\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,2]]},"published-print":{"date-parts":[[2022,12,2]]}},"alternative-id":["10.1515\/med-2022-0560"],"URL":"https:\/\/doi.org\/10.1515\/med-2022-0560","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}